Developed by Merck, the new cholesterol pill, can lower LDL levels by around 605 in adults with a genetic form of high ...

Merck’s new pill, enlicitide, lowered LDL cholesterol by up to 60% in a new trial The pill works just as well as traditional PCSK9 injections but could cost less Researchers hope to receive federal ...

Halozyme is seeing some progress in its global effort to defend intellectual property against alleged infringement by Merck & ...

Merck has unveiled a groundbreaking cholesterol-lowering pill, enlicitide, which could transform treatment for millions of Americans struggling with high LDL cholesterol. The once-daily oral ...

Merck, the company that introduced statins to the world nearly 40 years ago, has a new, intensely powerful pill that can slash levels of dangerous LDL cholesterol to levels almost never seen in adults ...

But nearly half of Merck's revenue is generated by a single product. That's oncology drug Keytruda, which has turned out to ...

Merck’s investigational antibody MK-2214 has received fast-track designation from the FDA for the treatment of Alzheimer’s disease. MK-2214 targets phosphorylated serine 413 tau (pS413), a marker of ...

Germany's Merck KGaA on Thursday agreed to use Boston-based Valo Health's drug research services in a collaboration focused ...

Merck's MK-2214 drug received fast-track designation from the Food and Drug Administration for treatment of Alzheimer's disease. The Rahway, N.J., company said Monday that it would present data this ...